The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management

• DOI: 10.1111/jch.14555
• Publication Date: 2022-10-05T05:58:21Z
• Authors: Kazuomi Kario; Ji‐Guang Wang; Yook‐Chin Chia; Tzung‐Dau Wang; Yan Li; Saulat Siddique; Jinho Shin; Yuda Turana; Peera Buranakitja...; Chen‐Huan Chen; Hao‐Min Cheng; Minh Van Huynh; Jennifer Nailes; Apichard Sukontha...; Yuqing Zhang; Jorge Sison; Arieska Ann Soenarta; Sungha Park; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Satoshi Hoshide
• Keywords: PREDICTOR; SURGE; hypertension; Asia; Consensus; JAPANESE; Antihypertensive Agents / therapeutic use; 610; RENAL DENERVATION; Blood Pressure; R Medicine (General); Guidelines; 03 medical and health sciences; 0302 clinical medicine; Blood Pressure Monitoring; Ambulatory; RECORDINGS; Diseases of the circulatory (Cardiovascular) system; Humans; Hypertension* / drug therapy; Asia / epidemiology; POPULATION; Antihypertensive Agents; Science & Technology; antihypertensive medication; morning; Hypertension* / epidemiology; Blood Pressure Monitoring, Ambulatory; HOME BLOOD-PRESSURE; EFFICACY; personalized approach; Circadian Rhythm; 3. Good health; bedtime dosing; Peripheral Vascular Disease; Hypertension* / diagnosis; RC666-701; Hypertension; Cardiovascular System & Cardiology; CORONARY-ARTERY-DISEASE; Blood Pressure / physiology; Life Sciences & Biomedicine; STROKE

AbstractMorning hypertension is an important clinical target in the management of hypertension for perfect 24‐h blood pressure (BP) control. Morning hypertension is generally categorized into two types: “morning surge” type and “sustained nocturnal and morning hypertension” type. The “morning surge” type is characterized by an exaggerated morning blood pressure surge (MBPS), and the “sustained nocturnal and morning hypertension” type with continuous hypertension from nighttime to morning (non‐dipper/riser type). They can be detected by home and ambulatory blood pressure measurements (HBPM and ABPM). These two forms of morning hypertension both increase the risk of cardiovascular and renal diseases, but may occur via different pathogenic mechanisms and are associated with different conditions. Morning hypertension should be treated to achieve a morning BP level of < 135/85 mmHg, regardless of the office BP. The second target morning BP levels is < 125/75 mmHg for high‐risk patients with morning hypertension and concomitant diseases. Morning hypertension is more frequently found in Asians, than in Westerners. Thus, the management of morning hypertension is especially important in Asia. The detection of morning hypertension and the individual home BP‐guided treatment approach targeting morning BP in combination with ABPM, and the optimal treatment of morning hypertension would reduce cardiovascular events in Asia.